申请人:Imperial Chemical Industries PLC
公开号:US05229414A1
公开(公告)日:1993-07-20
Compounds of the general formula I ##STR1## wherein R.sup.1 represents a halophenyl, dihalophenyl, nitrophenyl, cyanophenyl or trifluoromethylphenyl group; X represents a single bond, --CH.sub.2 --, --OCH.sub.2 --, SCH.sub.2, --S(O)--CH.sub.2 --, --S(O).sub.2 --CH.sub.2 -- or --CH.sub.2 CH.sub.2 -- R.sup.2 represents hydrogen or C.sub.1-3 alkyl; R.sup.3 represents a phenyl group substituted in the meta-position by a radical containing an organic base, an organic acid or a quaternary ammonium salt and optionally further substituted. R.sup.4 and R.sup.5 which may be the same or different each represents a C.sub.3-5 alkenyl, C.sub.3-5 alkynyl, C.sub.1-6 alkyl, or C.sub.4-7 cycloalkylalkyl group, or together with the intervening nitrogen atom represents a 4-7 membered heterocyclic ring, and the pharmaceutically acceptable salts thereof are useful for the treatment of hypertension and/or inflammation in the warm-blooded animals. Also disclosed are processes for their preparation and pharmaceutical compositions containing them.
通式I的化合物其中R.sup.1代表卤苯基、二卤苯基、硝基苯基、氰基苯基或三氟甲基苯基;X代表单键、--CH.sub.2 --、--OCH.sub.2 --、SCH.sub.2、--S(O)--CH.sub.2 --、--S(O).sub.2 --CH.sub.2 --或--CH.sub.2 CH.sub.2 --;R.sup.2代表氢或C.sub.1-3烷基;R.sup.3代表在间位被含有有机碱、有机酸或季铵盐基团取代的苯基,并可选择进一步取代。R.sup.4和R.sup.5可以相同也可以不同,每个代表C.sub.3-5烯基、C.sub.3-5炔基、C.sub.1-6烷基或C.sub.4-7环烷基烷基,或者与介于其间的氮原子一起代表一个4-7成员杂环,并且其药学上可接受的盐对于治疗温血动物的高血压和/或炎症是有用的。还公开了它们的制备方法和含有它们的药物组合物。